Novartis Super Bowl Commercials
We don't make the ads - We measure them
Pharmaceutical giant Novartis is returning to the Big Game in 2026 as the first pharma brand to commit to Super Bowl LX after making its impactful debut last year. To lead the creative for its second appearance, the company has tapped Publicis’ agency Fallon. While the specific campaign theme and celebrity talent remain unknown, the brand is expected to continue its focus on emotionally charged, unbranded health awareness. This move coincides with Novartis becoming the NFL's first-ever corporate pharmaceutical partner.
